OBI in-licensed “anti-Trop2 antibody” exclusive rights from Biosion

1.Date of occurrence of the event: 2021/12/08 2.Counterparty to the contract or commitment: Biosion, Inc. 3.Relationship with the Company: None 4.Starting and ending dates (or rescission date) of the contract or commitment: 2021/12/08 5.Major content (not applicable where rescinded): (1)OBI has entered into an exclusive license agreement of an anti-Trop2 humanized monoclonal antibody, BSI04702, for […]